AmeriCann, Inc. engages in the development and leasing of cannabis cultivation, processing and product manufacturing facilities. The company is headquartered in Denver, Colorado and currently employs 3 full-time employees. The company went IPO on 2013-09-10. The company has provisional licenses to produce cannabis-infused products, including beverages, edibles, topicals, and concentrates. The company designs GMP-certified cannabis extraction and product manufacturing infrastructure. Its flagship project is the Massachusetts Cannabis Center (MCC), which is developed on an over 52-acre parcel. MCC project is permitted for over 800,000 square feet of cannabis cultivation and processing infrastructure, which is being developed in phases to support both the existing medical cannabis and the emerging adult-use cannabis marketplace. The Company, through its subsidiary, AmeriCann Brands, Inc., has received two licenses from the Massachusetts Cannabis Control Commission to cultivate cannabis and provide extraction and product manufacturing support to the entire MCC project, as well as to other licensed cannabis farmers throughout the regulated market.

Industry: Services-Management Consulting Services Peers: CLS Holdings USA, Inc. Enveric Biosciences Inc /entities/nasc CNS Pharmaceuticals Inc Kiora Pharmaceuticals Inc GREEN HYGIENICS HOLDINGS INC. Johnson & Johnson Range Impact Inc Palisade Bio Inc